RCA-free adenoviral vector system and propagation method
US6482616B1 · kind B1 · utility
33Cited by
9References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 27, 1999 |
| Grant date | Nov 19, 2002 |
| Priority date | — |
| Expiry date | May 27, 2019 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S977/799
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides multiply deficient adenoviral vectors and complementing cell lines. Also provided are recombinants of the multiply deficient adenoviral vectors and a therapeutic method, particularly relating to gene therapy, vaccination, and the like, involving the use of such recombinants.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.